ArticleHelminthologia2026
Fasciolosis: Analytical approaches to post-treatment liver enzyme activity changes in cattle.
Article in Helminthologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study investigated the applicability of three different analytical approaches for assessing post-treatment changes in liver enzyme activity following anthelmintic therapy over a 21-day period in cattle naturally infected with fasciolosis. A total of 48 animals were allocated into four groups of 12 cows each: one untreated control group and three treatment groups. Treated cattle received the following anthelmintic combinations: ivermectin plus clorsulon (IVM+CLOR), levamisole plus oxyclozanide (LEV+OXY), and albendazole (ABZ). Biochemical assessments were performed using standardized kinetic and colorimetric methods in accordance with the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) guidelines. Pre- and post-treatment changes in hepatic enzymes (aspartate aminotransferase - AST, alanine aminotransferase - ALT) and cholestatic enzymes (alkaline phosphatase - ALP, gamma-glutamyl transferase - GGT) were evaluated. The analyses demonstrated comparable applicability and reliability of quantifying post-treatment enzyme changes when referenced either to pre-treatment or to the control group at the group level, rather than at the individual level. Among the enzymes assessed, all three analytical approaches showed agreeing results of significantly decreased GGT activity by 3.8 - 32.4 % and 21.6 - 47.5 % across treatment groups on Day 7 and 21, respectively, following flukicide administration. These findings underscore the importance of quantifying liver enzyme changes and highlight the relevance of GGT post-treatment alterations. The observed associations between flukicide therapy and biochemical liver profiles may provide a foundation for future studies aimed at elucidating the impact of treatment on clinic-biochemical patterns and the potential for liver recovery following the resolution of chronic fasciolosis in naturally infected cattle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.